A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.86.9.7877PMID 11549680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction

  2001cited by this paper
• The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

  2001cited by this paper
• Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats.

  2000cited by this paper
• Gastric Emptying: Comparison of Scintigraphic, Polyethylene Glycol Dilution, and Paracetamol Tracer Assessment Techniques

  2000cited by this paper
• The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies

  2000cited by this paper
• Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats.

  2000cited by this paper
• Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

  1999cited by this paper
• No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man

  1999cited by this paper
• Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.

  1999cited by this paper
• Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential.

  1999cited by this paper
• Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.

  1999cited by this paper
• Glucagon-like peptide-1: a potent regulator of food intake in humans

  1999cited by this paper
• Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

  1998cited by this paper
• Distal Small Bowel Hormones (Correlation with Fasting Antroduodenal Motility and Gastric Emptying)

  1998cited by this paper
• Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

  1998cited by this paper
• Normalization of fasting glycaemia by intravenous GLP‐1 ([7‐36 amide] or [7‐37]) in Type 2 diabetic patients

  1998cited by this paper
• Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

  1997cited by this paper
• Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• The benefits of modest weight loss in type II diabetes.

  1997cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

  1996cited by this paper
• Attenuated GLP-1 secretion in obesity: cause or consequence?

  1996cited by this paper
• Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

  1993cited by this paper
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

  1993cited by this paper
• Liquid gastric emptying assessed by direct and indirect techniques: radionuclide labelled liquid emptying compared with a simple paracetamol marker method.

  1985cited by this paper
• rapid communication Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2

  year unknowncited by this paper

• The effect of morning or evening fasted cycling on gastrointestinal function and appetite and metabolic responses in healthy males with overweight

  2025cites this paper
• Grains, Cereals, and Legumes: Implications in Glycemic Index and Perspectives

  2025cites this paper
• Vegetables and Glycemic Index: Exploring Their Correlation and Health Implications

  2025cites this paper
• The effects of protein supplementation on body composition after bariatric surgery: a systematic review and meta‐analysis of randomized controlled trials

  2025cites this paper
• GLP-1 and the Neurobiology of Eating Control: Recent Advances

  2025cites this paper
• Appetite-related Gut Hormone Responses to Feeding Across the Life Course

  2025cites this paper
• The efficacy of liraglutide-based drugs on the model of induced metabolic syndrome in experimental animals

  2025cites this paper
• Bidirectional regulation of free fatty acid receptors and non-alcoholic fatty liver disease.

  2025cites this paper
• Gut Microbiota in Women with Eating Disorders: A New Frontier in Pathophysiology and Treatment

  2025cites this paper
• The effect of consuming different dietary protein sources at breakfast upon self rated satiety, peptide YY, glucagon like peptide-1, and subsequent food intake in young and older adults

  2025cites this paper
• Measuring Temporal Dynamics of Satisfaction Differences Between Animal- and Plant-Based Foods.

  2025cites this paper
• Pharmacotherapy for Obesity: Recent Updates

  2025cites this paper
• GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management

  2024cites this paper
• Incretin-based therapy: a new horizon in diabetes management

  2024cites this paper
• Glucagon-Like Peptide Receptor-1 Agonists Used for Medically-Supervised Weight Loss in Patients With Hip and Knee Osteoarthritis: Critical Considerations for the Arthroplasty Surgeon

  2024cites this paper
• Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions

  2024influential citation
• The effects of gut microbiota on appetite regulation and the underlying mechanisms

  2024cites this paper
• Effects of physical form of β-lactoglobulin and calcium ingestion on GLP-1 secretion, gastric emptying and energy intake in humans: a randomised crossover trial

  2024cites this paper
• Association of quality and quantity of macronutrients intake with obesity, new anthropometric indices, lipid accumulation, and blood lipid risk index in Tehranian women

  2024cites this paper
• Obesogens: a unifying theory for the global rise in obesity

  2024cites this paper
• Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3-36 in the suppression of food, drug-seeking, and anxiogenesis.

  2024cites this paper
• Stronger control of eating 3 months after sleeve gastrectomy predicts successful weight loss outcomes at one year

  2024cites this paper
• The Influence of Acute and Chronic Exercise on Appetite and Appetite Regulation in Patients with Prediabetes or Type 2 Diabetes Mellitus—A Systematic Review

  2024cites this paper
• Targeting the incretin system in obesity and type 2 diabetes mellitus

  2024cites this paper
• Are glucagon-like peptide-1 receptor agonists anti-consummatory drugs?

  2024cites this paper
• Smart control lipid-based nanocarriers for fine-tuning gut hormone secretion

  2024cites this paper
• Resistant Dextrin Preexistence and Fate: Preparation, Physicochemical and Functional Properties, Physiological Activity, and Food Applications: A Review

  2024cites this paper
• Annual Prize Lecture 2024: Endogenous physiological mechanisms as basis for the treatment of obesity and type 2 diabetes

  2024cites this paper
• Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide (SHR20004), a novel GLP‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus

  2024cites this paper
• New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics.

  2023cites this paper
• The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials

  2023cites this paper
• A critical update on the leptin‐melanocortin system

  2023cites this paper
• Hunger & satiety signals: another key mechanism involved in the NAFLD pathway

  2023cites this paper
• Gut microbiota in obesity and related complications: Unveiling the complex interplay.

  2023cites this paper
• Oral Glucose has Little or no Effect on Appetite and Satiety Sensations Despite a Significant Gastrointestinal Response.

  2023cites this paper
• [Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review].

  2023cites this paper
• The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.

  2023cites this paper
• Applications of Enteroendocrine Cells (EECs) Hormone: Applicability on Feed Intake and Nutrient Absorption in Chickens

  2023cites this paper
• Starch-entrapped microspheres enhance gut microbiome-mediated anti-obesity effects of resistant starch in high-fat diet induced obese C57BL/6J mice.

  2023cites this paper
• The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour

  2023cites this paper
• GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 Diabetes mit Fokus auf Tirzepatid

  2023cites this paper
• Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity

  2023cites this paper
• Synbiotic as an adjunctive agent can be useful in the management of hyperglycemia in adults: An umbrella review and meta-research of meta-analysis studies

  2022cites this paper
• The History of Obesity Research

  2022cites this paper
• Effects of Ingesting Both Catechins and Chlorogenic Acids on Glucose, Incretin, and Insulin Sensitivity in Healthy Men: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial

  2022cites this paper
• Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

  2022cites this paper
• Mucosal and hormonal adaptations after Roux-en-Y gastric bypass.

  2022cites this paper
• Effect of branched-chain amino acids on food intake and indicators of hunger and satiety- a narrative summary

  2022cites this paper
• The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial

  2022influential citation
• The Enteroendocrine System in Obesity.

  2022cites this paper
• Metabolic variables of obese dogs with insulin resistance supplemented with yeast beta-glucan

  2022cites this paper
• Different Protein Sources Enhance 18FDG-PET/MR Uptake of Brown Adipocytes in Male Subjects

  2022cites this paper
• GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

  2022cites this paper
• Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases.

  2022cites this paper
• Nicotine and energy balance: A review examining the effect of nicotine on hormonal appetite regulation and energy expenditure.

  2021cites this paper
• Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

  2021cites this paper
• DOES PALM MID FRACTION AFFECT ADULT SATIETY?

  2021cites this paper
• The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review.

  2021cites this paper
• The effects of Glucagon Like Peptide-1 (GLP-1) on cardiac remodelling: exploring the role of medication and physiological modulation after metabolic surgery: a narrative review.

  2021cites this paper
• Effects of gastrointestinal delivery of non-caloric tastants on energy intake: a systematic review and meta-analysis

  2021cites this paper
• Effects of Whole Grain Intake, Compared with Refined Grain, on Appetite and Energy Intake: A Systematic Review and Meta-Analysis

  2021cites this paper
• Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids

  2021cites this paper
• Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review

  2021cites this paper
• Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes

  2021cites this paper
• Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake.

  2021cites this paper
• Peptides Involved in Body Weight Regulation

  2021cites this paper
• Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in the Weight Loss Among Obese Individuals: A Systematic Review

  2021cites this paper
• The Potential Role of Appetite in Mediating the Relationship of Whole Grains and Body Weight

  2021cites this paper
• Incretins in the Therapy of Diabetic Kidney Disease

  2021cites this paper
• Exendin(9‐39)NH2: Recommendations for clinical use based on a systematic literature review

  2021cites this paper
• Effect of intestinal microbiota imbalance associated with chronic hepatitis B virus infection on the expression of microRNA‑192 and GLP‑1.

  2021cites this paper
• Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products

  2021cites this paper
• A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol

  2021cites this paper
• Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics

  2021cites this paper
• Glucagon-like peptide-1

  2021cites this paper
• Intestinal MYC modulates obesity-related metabolic dysfunction

  2021cites this paper
• Advances in GLP-1 treatment: focus on oral semaglutide

  2021cites this paper
• The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update

  2021cites this paper
• A brief review on newer Glucagon like Peptide-1 analogues

  2020cites this paper
• Effect of oral or intragastric delivery of the bitter tastant quinine on food intake and appetite sensations: a randomised crossover trial

  2020cites this paper
• Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control

  2020cites this paper
• Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists

  2020cites this paper
• Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection

  2020cites this paper
• Neurological Modulations of Sleep

  2020cites this paper
• Interacción entre la función reproductiva y metabólica: caracterización del papel de factores neuroendocrinos y el sensor energético, proteína quinasa activada por AMP (AMPK)

  2020cites this paper
• Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients.

  2020cites this paper
• Dietary squid paste supplementation promotes feed intake via brain-gut dynamic response in Chinese soft-shelled turtle Pelodiscus sinensis

  2020influential citation
• Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans.

  2020cites this paper
• Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study.

  2020cites this paper
• On Meal Effects and DPP-4 Inhibition Islet- and Incretin Hormones in Health and Type 2 Diabetes

  2020cites this paper
• Developmental Origins and Roles of Intestinal Enteroendocrine Hormones

  2020cites this paper
• Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence

  2020cites this paper
• Incretins in obesity and diabetes

  2020cites this paper
• Incretin Physiology and Pharmacology in the Intensive Care Unit.

  2019cites this paper
• A Plant-Based Meal Stimulates Incretin and Insulin Secretion More Than an Energy- and Macronutrient-Matched Standard Meal in Type 2 Diabetes: A Randomized Crossover Study

  2019cites this paper
• Intraintestinal Delivery of Tastants Using a Naso-Duodenal-Ileal Catheter Does Not Influence Food Intake or Satiety

  2019cites this paper
• Repenser la désinhibition alimentaire dans l’obésité, sous l’angle de l’hypothèse de l’addiction à l’alimentation

  2019cites this paper
• Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities

  2019cites this paper
• Medications development for food-based and drug use disorders.

  2019cites this paper
• The Role of Glucagon-Like Peptide-1 in Energy Homeostasis

  2019cites this paper